Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease.
4-phenylbutyrate (PBA) is a small molecule that restores cognitive deficits in animal models of Alzheimer's disease (AD). Although the molecular basis of the cognitive benefits of PBA remains unknown, a multi-modal/multi-target mechanism has been proposed. Putative targets of this drug are diff...
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | info:eu-repo/semantics/article |
| اللغة: | eng |
| منشور في: |
Bentham Science Publ LTD
2012
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://hdl.handle.net/10171/23299 |